- Home
- Rituxipca 500 mg Injection
Rituxipca 500 mg Injection Substitute
Rituxipca 500 mg Injection Substitute
Emtux 500 mg Injection 50 ml
by Others
₹773.42per tabletMabtas N 500 mg Injection 50 ml
by Others
₹767.90per tabletMaball 500 mg Injection 50 ml
by Others
₹658.77per tabletMabtas RA 500 Injection 50 ml
by Others
₹42661.00per tabletLupiximab 500mg Injection
by Others
₹240.91per tabletEnfiera 500 Injection 1's
by Others
₹34980.00per tabletReditux 500 Injection 1's
by Others
₹35588.40per tabletRuximonab 500 mg Injection 50 ml
by Others
₹640.00per tabletRituxirel RN 500 mg Injection 50 ml
by Others
₹699.60per tabletRituxem 500 mg Injection 50 ml
by Others
₹699.60per tabletRitucad 500 mg Injection 50 ml
by Others
₹699.60per tabletRituxipan 500 mg Injection 50 ml
by Others
₹851.56per tabletRituxy 500 Injection 50 ml
by Others
₹760.98per tabletRixilta 500 Injection 50 ml
by Others
₹623.95per tabletVortuxi 500 mg Injection 50 ml
by Others
₹699.60per tablet
Verified Ingredients and Effects
Composition:
RITUXIMAB-500MG
Uses:
Rituxipca 500 mg Injection is used in the treatment of Non-Hodgkin's disease, rheumatoid arthritis, chronic lymphocytic leukaemia, granulomatosis and pemphigus vulgaris. The detailed uses of Rituxipca 500 mg Injection are as follows:<br/>• Non-Hodgkin’s Lymphoma (NHL): Rituxipca 500 mg Injection is used to treat Non-Hodgkin’s Lymphoma alone or with chemotherapy.<br/>• Chronic Lymphocytic Leukemia (CLL): Rituxipca 500 mg Injection is used in the treatment of Chronic Lymphocytic Leukemia (CLL) and B-cell Acute Lymphoblastic Leukemia (B-ALL.<br/>• Rheumatoid Arthritis (RA): Rituxipca 500 mg Injection is used in the treatment of rheumatoid arthritis.<br/>• Granulomatosis with Polyangiitis (GPA) and Microscopic Polyangiitis (MPA): Rituxipca 500 mg Injection helps to treat Granulomatosis with Polyangiitis and Microscopic Polyangiitis.<br/>• Pemphigus Vulgaris: Rituxipca 500 mg Injection is used to treat pemphigus vulgaris for moderate to severe cases.<br/>
Medicinal Benefits:
Rituxipca 500 mg Injection contains Rituximab, which belongs to the class of monoclonal antibodies. It works by inhibiting the DNA and RNA transcription that is essential for cancer cell growth. This helps prevent the growth and further spread of cancerous or non-cancerous cells. On the other hand, Rituxipca 500 mg Injection works by interfering with the immune system process that causes inflammation in the joint tissues. Thus, it reduces pain and inflammation and prevents joint damage and disease progression over time.
FAQs
Rituxipca 500 mg Injection is used to treat Non-Hodgkin’s disease, rheumatoid arthritis, chronic lymphocytic leukaemia, granulomatosis and pemphigus vulgaris.
Rituxipca 500 mg Injection contains Rituximab, which works by inhibiting the DNA and RNA transcription that is essential for cancer cell growth.
Rituxipca 500 mg Injection may cause bowel obstruction and perforation, reactivation of Hepatitis B infection, Cardiac arrhythmias, tumour lysis syndrome, and angina in some patients. Hence, inform your oncologist about your complete medical history, including current medication, to rule out any side effects/interactions.
Rituxipca 500 mg Injection contains the active substance rituximab. This is a type of protein called a monoclonal antibody.
The common side effects of Rituxipca 500 mg Injection are pale skin, painful urination, night sweats, flushing, back pain, nausea, vomiting, diarrhoea, stomach pain, mouth sores, peeling of skin, injection site reactions and pain at the site of injection. If any of these side effects persist or worsen, please consult your doctor.